Page last updated: 2024-10-19

phytic acid and Leishmaniasis, Visceral

phytic acid has been researched along with Leishmaniasis, Visceral in 1 studies

Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Da Costa, H1
Adatrao, V1
Merchant, S1

Other Studies

1 other study available for phytic acid and Leishmaniasis, Visceral

ArticleYear
A radiocolloid study of the reticulo-endothelial system in tropical diseases.
    Nuklearmedizin. Nuclear medicine, 1979, Volume: 18, Issue:3

    Topics: Child; Colloids; Echinococcosis; Humans; Leishmaniasis, Visceral; Liver Cirrhosis; Malaria; Mononucl

1979